Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

BACKGROUND: Direct-acting antivirals have been used for decompensated cirrhotic patients with hepatitis C virus (HCV) infection. However, the benefits in Chinese patients with decompensated cirrhosis are unclear. METHODS: Thirty patients with HCV infection and decompensated cirrhosis were administer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Infect Agent Cancer
Autors principals: Ji, Fanpu, Wang, Wenjun, Dang, Shuangsuo, Wang, Shengbang, Li, Burong, Bai, Dan, Zhao, Wenxue, Deng, Hong, Tian, Changyin, Li, Zongfang
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5598030/
https://ncbi.nlm.nih.gov/pubmed/28924449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13027-017-0158-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars